The oral presentation resumes all goals and obstacles we have met so far in the design of our clinical study involving engineered muscle-derived stem cells for the treatment of Duchenne muscular dystrophy.
Preclinical experience and perspectives of a clinical trial using CD133 stem cells / Y. Torrente. ((Intervento presentato al convegno EMBO tenutosi a Manchester nel 2015.
Preclinical experience and perspectives of a clinical trial using CD133 stem cells
Y. TorrentePrimo
2015
Abstract
The oral presentation resumes all goals and obstacles we have met so far in the design of our clinical study involving engineered muscle-derived stem cells for the treatment of Duchenne muscular dystrophy.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.